Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Outlook Therapeutics has received mostly bullish ratings, which indicates a positive outlook for the company's stock. Additionally, the increase in the average price target over the past month suggests that analysts are becoming more optimistic about the company's future performance.